Toll Free: 1-888-928-9744
Published: Oct, 2018 | Pages:
96 | Publisher: QYResearch
Industry: Healthcare | Report Format: Electronic (PDF)
In 2017, the global Spinal Muscular Atrophy market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Spinal Muscular Atrophy development in United States, Europe and China. The key players covered in this study Lonis Pharmaceuticals F. Hoffmann-La Roche AveXis Novartis Cytokinetics Ionis Pharmaceuticals ... Market segment by Type, the product can be split into Early Stage Candidates Late Stage Candidates Market segment by Application, split into Hospital Clinic Others Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Central & South America The study objectives of this report are: To analyze global Spinal Muscular Atrophy status, future forecast, growth opportunity, key market and key players. To present the Spinal Muscular Atrophy development in United States, Europe and China. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by product type, market and key regions. In this study, the years considered to estimate the market size of Spinal Muscular Atrophy are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Spinal Muscular Atrophy Market Size Growth Rate by Type (2013-2025) 1.4.2 Early Stage Candidates 1.4.3 Late Stage Candidates 1.5 Market by Application 1.5.1 Global Spinal Muscular Atrophy Market Share by Application (2013-2025) 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Spinal Muscular Atrophy Market Size 2.2 Spinal Muscular Atrophy Growth Trends by Regions 2.2.1 Spinal Muscular Atrophy Market Size by Regions (2013-2025) 2.2.2 Spinal Muscular Atrophy Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Spinal Muscular Atrophy Market Size by Manufacturers 3.1.1 Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018) 3.1.2 Global Spinal Muscular Atrophy Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global Spinal Muscular Atrophy Market Concentration Ratio (CR5 and HHI) 3.2 Spinal Muscular Atrophy Key Players Head office and Area Served 3.3 Key Players Spinal Muscular Atrophy Product/Solution/Service 3.4 Date of Enter into Spinal Muscular Atrophy Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018) 4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018) 5 United States 5.1 United States Spinal Muscular Atrophy Market Size (2013-2018) 5.2 Spinal Muscular Atrophy Key Players in United States 5.3 United States Spinal Muscular Atrophy Market Size by Type 5.4 United States Spinal Muscular Atrophy Market Size by Application 6 Europe 6.1 Europe Spinal Muscular Atrophy Market Size (2013-2018) 6.2 Spinal Muscular Atrophy Key Players in Europe 6.3 Europe Spinal Muscular Atrophy Market Size by Type 6.4 Europe Spinal Muscular Atrophy Market Size by Application 7 China 7.1 China Spinal Muscular Atrophy Market Size (2013-2018) 7.2 Spinal Muscular Atrophy Key Players in China 7.3 China Spinal Muscular Atrophy Market Size by Type 7.4 China Spinal Muscular Atrophy Market Size by Application 8 Japan 8.1 Japan Spinal Muscular Atrophy Market Size (2013-2018) 8.2 Spinal Muscular Atrophy Key Players in Japan 8.3 Japan Spinal Muscular Atrophy Market Size by Type 8.4 Japan Spinal Muscular Atrophy Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018) 9.2 Spinal Muscular Atrophy Key Players in Southeast Asia 9.3 Southeast Asia Spinal Muscular Atrophy Market Size by Type 9.4 Southeast Asia Spinal Muscular Atrophy Market Size by Application 10 India 10.1 India Spinal Muscular Atrophy Market Size (2013-2018) 10.2 Spinal Muscular Atrophy Key Players in India 10.3 India Spinal Muscular Atrophy Market Size by Type 10.4 India Spinal Muscular Atrophy Market Size by Application 11 Central & South America 11.1 Central & South America Spinal Muscular Atrophy Market Size (2013-2018) 11.2 Spinal Muscular Atrophy Key Players in Central & South America 11.3 Central & South America Spinal Muscular Atrophy Market Size by Type 11.4 Central & South America Spinal Muscular Atrophy Market Size by Application 12 International Players Profiles 12.1 Lonis Pharmaceuticals 12.1.1 Lonis Pharmaceuticals Company Details 12.1.2 Company Description and Business Overview 12.1.3 Spinal Muscular Atrophy Introduction 12.1.4 Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) 12.1.5 Lonis Pharmaceuticals Recent Development 12.2 F. Hoffmann-La Roche 12.2.1 F. Hoffmann-La Roche Company Details 12.2.2 Company Description and Business Overview 12.2.3 Spinal Muscular Atrophy Introduction 12.2.4 F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018) 12.2.5 F. Hoffmann-La Roche Recent Development 12.3 AveXis 12.3.1 AveXis Company Details 12.3.2 Company Description and Business Overview 12.3.3 Spinal Muscular Atrophy Introduction 12.3.4 AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018) 12.3.5 AveXis Recent Development 12.4 Novartis 12.4.1 Novartis Company Details 12.4.2 Company Description and Business Overview 12.4.3 Spinal Muscular Atrophy Introduction 12.4.4 Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018) 12.4.5 Novartis Recent Development 12.5 Cytokinetics 12.5.1 Cytokinetics Company Details 12.5.2 Company Description and Business Overview 12.5.3 Spinal Muscular Atrophy Introduction 12.5.4 Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018) 12.5.5 Cytokinetics Recent Development 12.6 Ionis Pharmaceuticals 12.6.1 Ionis Pharmaceuticals Company Details 12.6.2 Company Description and Business Overview 12.6.3 Spinal Muscular Atrophy Introduction 12.6.4 Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) 12.6.5 Ionis Pharmaceuticals Recent Development 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details
List of Tables and Figures Table Spinal Muscular Atrophy Key Market Segments Table Key Players Spinal Muscular Atrophy Covered Table Global Spinal Muscular Atrophy Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global Spinal Muscular Atrophy Market Size Market Share by Type 2013-2025 Figure Early Stage Candidates Figures Table Key Players of Early Stage Candidates Figure Late Stage Candidates Figures Table Key Players of Late Stage Candidates Table Global Spinal Muscular Atrophy Market Size Growth by Application 2013-2025 (Million US$) Figure Hospital Case Studies Figure Clinic Case Studies Figure Others Case Studies Figure Spinal Muscular Atrophy Report Years Considered Table Global Spinal Muscular Atrophy Market Size 2013-2025 (Million US$) Figure Global Spinal Muscular Atrophy Market Size and Growth Rate 2013-2025 (Million US$) Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2025 (Million US$) Table Global Spinal Muscular Atrophy Market Size by Regions 2013-2018 (Million US$) Table Global Spinal Muscular Atrophy Market Share by Regions 2013-2018 Figure Global Spinal Muscular Atrophy Market Share by Regions 2013-2018 Figure Global Spinal Muscular Atrophy Market Share by Regions 2018 Table Market Top Trends Table Global Spinal Muscular Atrophy Revenue by Manufacturers (2013-2018) (Million US$) Table Global Spinal Muscular Atrophy Market Share by Manufacturers (2013-2018) Figure Global Spinal Muscular Atrophy Market Share by Manufacturers in 2018 Table Global Spinal Muscular Atrophy Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Spinal Muscular Atrophy Product/Solution/Service Table Date of Enter into Spinal Muscular Atrophy Market Table Mergers & Acquisitions, Expansion Plans Table Global Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table Global Spinal Muscular Atrophy Market Size Share by Type (2013-2018) Figure Global Spinal Muscular Atrophy Market Size Market Share by Type (2013-2018) Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table Global Spinal Muscular Atrophy Market Size Share by Application (2013-2018) Figure Global Spinal Muscular Atrophy Market Size Market Share by Application (2013-2018) Figure Global Spinal Muscular Atrophy Revenue Market Share by Application in 2017 Figure United States Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table United States Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table United States Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table United States Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table United States Spinal Muscular Atrophy Market Share by Type (2013-2018) Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table United States Spinal Muscular Atrophy Market Share by Application (2013-2018) Figure Europe Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table Europe Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table Europe Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table Europe Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table Europe Spinal Muscular Atrophy Market Share by Type (2013-2018) Table Europe Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table Europe Spinal Muscular Atrophy Market Share by Application (2013-2018) Figure China Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table China Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table China Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table China Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table China Spinal Muscular Atrophy Market Share by Type (2013-2018) Table China Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table China Spinal Muscular Atrophy Market Share by Application (2013-2018) Figure Japan Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table Japan Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table Japan Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table Japan Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table Japan Spinal Muscular Atrophy Market Share by Type (2013-2018) Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table Japan Spinal Muscular Atrophy Market Share by Application (2013-2018) Figure Southeast Asia Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table Southeast Asia Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table Southeast Asia Spinal Muscular Atrophy Market Share by Type (2013-2018) Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table Southeast Asia Spinal Muscular Atrophy Market Share by Application (2013-2018) Figure India Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table India Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table India Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table India Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table India Spinal Muscular Atrophy Market Share by Type (2013-2018) Table India Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table India Spinal Muscular Atrophy Market Share by Application (2013-2018) Figure Central & South America Spinal Muscular Atrophy Market Size 2013-2018 (Million US$) Table Central & South America Key Players Spinal Muscular Atrophy Revenue (2017-2018) (Million US$) Table Central & South America Key Players Spinal Muscular Atrophy Market Share (2017-2018) Table Central & South America Spinal Muscular Atrophy Market Size by Type (2013-2018) (Million US$) Table Central & South America Spinal Muscular Atrophy Market Share by Type (2013-2018) Table Central & South America Spinal Muscular Atrophy Market Size by Application (2013-2018) (Million US$) Table Central & South America Spinal Muscular Atrophy Market Share by Application (2013-2018) Table Lonis Pharmaceuticals Company Details Table Lonis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018) (Million US$) Figure Lonis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018) Table Lonis Pharmaceuticals Recent Development Table F. Hoffmann-La Roche Company Details Table F. Hoffmann-La Roche Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$) Figure F. Hoffmann-La Roche Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018) Table F. Hoffmann-La Roche Recent Development Table AveXis Company Details Table AveXis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$) Figure AveXis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018) Table AveXis Recent Development Table Novartis Company Details Table Novartis Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$) Figure Novartis Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018) Table Novartis Recent Development Table Cytokinetics Company Details Table Cytokinetics Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$) Figure Cytokinetics Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018) Table Cytokinetics Recent Development Table Ionis Pharmaceuticals Company Details Table Ionis Pharmaceuticals Revenue in Spinal Muscular Atrophy Business (2013-2018)(Million US$) Figure Ionis Pharmaceuticals Revenue Growth Rate in Spinal Muscular Atrophy Business (2013-2018) Table Ionis Pharmaceuticals Recent Development Table Global Spinal Muscular Atrophy Market Size by Regions (Million US$) 2018-2025 Figure Global Spinal Muscular Atrophy Market Size Share by Regions (2018-2025) Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025 Figure United States Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Figure Europe Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Figure China Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Figure Japan Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Figure India Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Figure Central & South America Spinal Muscular Atrophy Market Size Forecast (2018-2025)(Million USD) Table Global Spinal Muscular Atrophy Market Size by Product (2018-2025) (Million US$) Figure Global Spinal Muscular Atrophy Market Size by Product (2018-2025) Figure Global Spinal Muscular Atrophy Market Size by Product in 2025 Table Global Spinal Muscular Atrophy Market Size by Application (2018-2025) (Million US$) Figure Global Spinal Muscular Atrophy Market Size by Application (2018-2025) Figure Global Spinal Muscular Atrophy Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.